Research of CYP2C9 and CYP2C19 gene polymorphism in evaluation of treatment effectiveness in children with epilepsy

被引:0
|
作者
Guzeva, V. I.
Guzeva, V. [1 ]
Guzeva, O. [1 ]
机构
[1] St Petersburg State Pediat Med Univ, Dept Neurol, St Petersburg, Russia
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P4119
引用
收藏
页码:430 / 430
页数:1
相关论文
共 50 条
  • [41] Effects of polymorphisms in CYP2D6, CYP2C9, and CYP2C19 on trimipramine pharmacokinetics
    Kirchheiner, J
    Müller, G
    Meineke, I
    Wernecke, KD
    Roots, I
    Brockmöller, J
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (05) : 459 - 466
  • [42] Determination of CYP2C9 and CYP2C19 genetic polymorphisms in Behcet's disease
    Tamer, L
    Yildirim, H
    Api, H
    Karakas, S
    Degirmenci, U
    Ayaz, L
    Ercan, B
    Baz, K
    Tursen, U
    Atik, U
    FEBS JOURNAL, 2005, 272 : 137 - 137
  • [43] The metabolism of CYP2C9 and CYP2C19 for gliclazide by homology modeling and docking study
    Yao, Yuan
    Han, Wei-Wei
    Zhou, Yi-Han
    Li, Ze-Sheng
    Li, Qiang
    Chen, Xiao-Yan
    Zhong, Da-Fang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (02) : 854 - 861
  • [44] Distribution of CYP2C9*13 allele in the Chinese Han and the long-range haplotype containing CYP2C9*13 and CYP2C19*2
    Si, Dayong
    Wang, Juan
    Zhang, Yifan
    Zhong, Dafang
    Zhou, Hui
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (06) : 342 - 345
  • [45] Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment
    Crettol, S
    Déglon, JJ
    Besson, J
    Croquette-Krokkar, M
    Gothuey, I
    Hämmig, R
    Monnat, M
    Hüttemann, H
    Baumann, P
    Eap, CB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (06) : 593 - 604
  • [46] Effects of CYP2C19 and CYP2C9 polymorphisms on the efficacy and plasma concentration of lacosamide in pediatric patients with epilepsy in China
    Zhao, Ting
    Li, Hong-jian
    Zhang, Hui-lan
    Yu, Jing
    Feng, Jie
    Cui, Long
    Sun, Ke-Fang
    Sun, Yan
    Yu, Lu-hai
    EUROPEAN JOURNAL OF PEDIATRICS, 2024, 184 (01)
  • [47] Influence of CYP2C19*2, CYP2C19*3 and CYP2C9*3 genotypes on anti-epileptic drugs resistance of refractory epileptics
    Zhang Qingxia
    Jiang DeChun
    Wang YuQin
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 227P - 227P
  • [48] RESEARCH CYP2C19*2 GENE POLYMORPHISM WITH ACUTE CORONARY SYNDROME
    Wangjiawang, Liufan
    Cuiwei, Xieruiqin
    Yangxiuchun, Lujingchao
    Peiweina, Liufan
    HEART, 2012, 98 : E60 - E61
  • [49] DISTRIBUTION OF THE CYP2C19*2, CYP2C19*3 AND CYP2C19*4 GENE VARIANTS IN A ROMANIAN POPULATION
    Buzoianu, A. D.
    Trifa, A. P.
    Popp, R. A.
    Militaru, C. F.
    Bocsan, C., I
    Popp, I., V
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 80 - 80
  • [50] CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population
    Scott, StuartA
    Edelmann, Lisa
    Kornreich, Rutb
    Erazo, Monica
    Desnick, Robert J.
    PHARMACOGENOMICS, 2007, 8 (07) : 721 - 730